Which closed-end funds own Relay Therapeutics Inc?
5 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $11.1M. Security type: common equity. Country: United States. CUSIP 75943R102 · ISIN US75943R1023 · ticker RLAY.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| HQL abrdn Life Sciences Investors | Healthcare | 0.51% | $3.5M | 186,561 sh | $690M | 3.4% discount | Jun 30, 2026 |
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 0.32% | $3.4M | 183,230 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 0.25% | $3.5M | 185,608 sh | $1.4B | 7.1% discount | Jun 30, 2026 |
| BME BlackRock Health Sciences Trust | Healthcare | 0.10% | $570K | 30,472 sh | $573M | 2.8% discount | Jun 30, 2026 |
| GRX Gabelli Healthcare & WellnessRx Trust | Healthcare | 0.08% | $187K | 10,000 sh | $228M | NAV unavailable | Jun 30, 2026 |
5 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: RELAY THERAPEUTICS INC.
Issuer-level search for “RLAY” → · Compare two funds’ portfolios →